These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16164655

  • 21. Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
    Nishio S, Hatanaka M, Takeda H, Iseda T, Iwata H, Yokoyama M.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S394-6. PubMed ID: 10541271
    [Abstract] [Full Text] [Related]

  • 22. The role of macromolecules in the formation of kidney stones.
    Rimer JD, Kolbach-Mandel AM, Ward MD, Wesson JA.
    Urolithiasis; 2017 Feb; 45(1):57-74. PubMed ID: 27913854
    [Abstract] [Full Text] [Related]

  • 23. Inhibitors of stone formation.
    Worcester EM.
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [Abstract] [Full Text] [Related]

  • 24. A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine.
    Wang T, Thurgood LA, Grover PK, Ryall RL.
    BJU Int; 2010 Dec; 106(11):1768-74. PubMed ID: 20230382
    [Abstract] [Full Text] [Related]

  • 25. The effect of intracrystalline and surface-bound osteopontin on the attachment of calcium oxalate dihydrate crystals to Madin-Darby canine kidney (MDCK) cells in ultrafiltered human urine.
    Thurgood LA, Sørensen ES, Ryall RL.
    BJU Int; 2012 Apr; 109(7):1100-9. PubMed ID: 21883862
    [Abstract] [Full Text] [Related]

  • 26. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP, Bledsoe SB, Smith SB, Bushinsky DA.
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Changes in urine macromolecular composition during processing.
    Maslamani S, Glenton PA, Khan SR.
    J Urol; 2000 Jul; 164(1):230-6. PubMed ID: 10840465
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T, Takemoto M, Itatani H, Takaha M, Sonoda T.
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [Abstract] [Full Text] [Related]

  • 34. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
    Nishio S, Hatanaka M, Takeda H, Aoki K, Iseda T, Iwata H, Yokoyama M.
    Mol Urol; 2000 Sep; 4(4):383-90. PubMed ID: 11156706
    [Abstract] [Full Text] [Related]

  • 37. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals.
    Farell G, Huang E, Kim SY, Horstkorte R, Lieske JC.
    J Am Soc Nephrol; 2004 Dec; 15(12):3052-62. PubMed ID: 15579508
    [Abstract] [Full Text] [Related]

  • 38. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S, Miyata K, Kohjimoto Y, Ohkawa T.
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.